Blog and News REACH authorisation fees increased

REACH authorisation fees increased

Regulation 2018/895 has been published in the European Union. The regulation increases the application fees for the authorisation of the use of substances listed in Annex XIV of REACH.

Fees payable to ECHA, are as follows:

Size of enterprise Base fee (EUR) Additional substance fee (EUR) Additional use fee (EUR)
Standard 54,100 10,820 48,690
Medium 40,575 8,115 36,518
Small 24,345 4,869 21,911
Micro 5,410 1,082 4,869

The new fees apply for applications submitted from 15 July 2018.

Please leave your comments:


Consultation opens on RoHS exemptions
Date: 19/03/2019

Consultation opens on RoHS exemptions

The Oeko-Institut and Fraunhofer IZM have launched a stakeholder consultation on behalf of the European Commission on requests for three new RoHS exemptions and the renewal of three existing RoHS exemption.

Read more
Bevacizumab added to Proposition 65 List
Date: 13/03/2019

Bevacizumab added to Proposition 65 List

The California Office of Environmental Health Hazard Assessment has updated the list of chemicals known to the state to cause cancer or reproductive toxicity to include Bevacizumab. This chemical is sold under the trade name Avastin and is used as a cancer treatment.

Read more